Leveraging Commercial Packaging Expertise Early To Ensure Successful Scaling From The Clinical Stage

By Nick Seibert, Account Executive, Sharp Packaging

Pharmaceutical companies lose $600+ billion each year due to medication non-adherence¹. In general, about 30% of patients fail to fill their second prescription², 50% do not implement the prescription as prescribed³, and 40% discontinue treatment after the first year⁴.

While there are a number of influencing factors, focusing on the development of commercial packaging in early-stage clinical trials is one area that can help improve patient adherence and patient retention ultimately reducing these losses.

Here, Nick Seibert, Account Executive, Sharp Packaging explores how early collaboration between clinical and commercial teams can create significant value for sponsors.